Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Oxytocin on Familial Interactions
NCT02302209Phase 1Completed
- Sponsor
- University of California, San Francisco
- Start
- Apr 2011
- Primary completion
- Oct 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1 trial of oxytocin in schizophrenia and Autism Spectrum Disorder (ASD) (2 arms), sponsored by University of California, San Francisco. Primary endpoint: Change in Negative Expressed Emotion at 4 hours. Started Apr 2011; status: completed.
02
Drugs
oxytocin
03
Conditions
schizophreniaAutism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT02302209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02302209.